NCT05877664View on ClinicalTrials.gov

Study of ZG0895.HCl in Patients With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 8, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Advanced Solid Tumor
Interventions
DRUG

ZG0895 Hydrochloride for Injection

The dose escalation of ZG0895.HCl is set as 0.06, 0.12, 0.18, 0.37, 0.75, 1.50, 2.25, 3.00, and 3.75 mg/m\^2 groups, subcutaneous (SC) injection once a week (QW)

Trial Locations (1)

310022

RECRUITING

Zhejiang Cancer Hospital, Zhejiang

All Listed Sponsors
lead

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

INDUSTRY